Abstract
Purpose
Research to date on fear of cancer recurrence (FCR) shows that moderate to high FCR affects 22–87 % of cancer survivors and is associated with higher psychological morbidity (Simard et al J Cancer Surviv 7:300–322, 2013). Despite growing research interest in FCR, the lack of consensus on its definition and characteristics when it reaches a clinical level has impeded knowledge transfer into patient services.
Methods
In order to address these gaps, expert researchers, policy makers, trainees, and patient advocates attended a 2-day colloquium at the University of Ottawa in August 2015. A Delphi method was used to identify the most relevant definition of FCR, and the attendees generated possible diagnostic characteristics of clinical FCR.
Results
After three rounds of discussion and voting, the attendees reached consensus on a new definition of FCR: “Fear, worry, or concern relating to the possibility that cancer will come back or progress.” Regarding clinical FCR, five possible characteristics were proposed: (1) high levels of preoccupation, worry, rumination, or intrusive thoughts; (2) maladaptive coping; (3) functional impairments; (4) excessive distress; and (5) difficulties making plans for the future.
Conclusions
The new proposed definition of FCR reflects the broad spectrum in which patients experience FCR. A consensual definition of FCR and the identification of the essential characteristics of clinical FCR are necessary to accurately and consistently measure FCR severity and to develop effective interventions to treat FCR. We hope this broad definition can encourage further research and the development of inclusive policies for all cancer patients and survivors who are struggling with this issue.
References
Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7:300–322. doi:10.1007/s11764-013-0272-z
Crist JV, Grunfeld EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology 22:978–986. doi:10.1002/pon.3114
Koch L, Jansen L, Brenner H, Arndt V (2013) Fear of recurrence and disease progression in long term (≥5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology 22:1–11. doi:10.1002/pon.3022
Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C (2012) Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology 21:571–587. doi:10.1002/pon.2070
Cancer Australia (2014) Recommendations for the identification and management of fear of cancer recurrence in adult cancer survivors. Retrieved from: http://guidelines.canceraustralia.gov.au/guidelines/fear_of_recurrence/ch01.php. Accessed 1 Dec 2015
Vickberg SM (2003) The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med 25:16–24. doi:10.1207/S15324796ABM2501_03
Lee-Jones C, Humphris G, Dixon R, Hatcher MB (1997) Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 6:95–105
Lebel S, Ozakinci G, Humphris G, Thewes B, Prins J, Dinkel A, Butow P (2016) Current state and future prospects of research on fear of cancer recurrence. Psychooncology
Iqbal S, Pipon-Young L (2009) The Delphi method. Psychologist 22:598–601
Northouse LL (1981) Mastectomy patients and the fear of cancer recurrence. Cancer Nurs 4:213–220
Simard S, Savard J (2009) Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of recurrence. Support Care Cancer 17:241–251. doi:10.1007/s00520-008-0444-y
Herschbach P, Dinkel A (2014) Fear of progression. In: Goerling U (ed) Psycho-oncology. Recent results in cancer research, vol 197. Springer, Berlin, pp 11–29
Custers JAE, Gielissen MFM, Janssen SHV, de Wilt JHW, Prins JB (2015) Fear of cancer recurrence in colorectal cancer survivors. Support Care Cancer. doi:10.1007/s00520-015-2808-4
Simard S, Savard J, Ivers H (2010) Fear of cancer recurrence: specific profiles and nature of intrusive thoughts. J Cancer Surviv 4:361–371. doi:10.1007/s11764-010-0136-8
Acknowledgments
This work was supported by a Dissemination and Planning grant (# PCS 142019) from the Canadian Institutes of Health Research and by a Meeting Grant from the University of Ottawa awarded to Sophie Lebel.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Rosalind Bell, Peter Dorfman, Josée Savard, Margaret Fitch, Lee Westmaas, Louise Sharpe, Allan “Ben” Smith, Marieke van de Wal, José Custers, Jacqueline Galicia, Danielle Petricone-Westwood, Georden Jones, Christina Tomei, Caroline Séguin Leclair, Nicole Rutkowski, Isabelle Merckaert, and Florence Lewis are attendees of the University of Ottawa Fear of Cancer Recurrence Colloquium. We would like to thank Sebastien Simard and Christine Maheu for the comments on the organization of the Colloquium.
The first author has full control of all primary data and agrees to allow the journal to review the data if requested.
Rights and permissions
About this article
Cite this article
Lebel, S., Ozakinci, G., Humphris, G. et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 24, 3265–3268 (2016). https://doi.org/10.1007/s00520-016-3272-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3272-5